Serial 99410769

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Sept 2025 filing date already counts against anyone who files later.

Record

Serial number

99410769

Mark type

Design / logo

Filed

24 Sept 2025

Published for opposition

14 Apr 2026

Attorney of record

Anthony J. DiMarino

Goods and services

• Class 001 — Chemicals: Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals; Reagents for scientific or medical research use; Reagents for research purposes; Reagents for scientific purposes; Reagents for scientific use; Chemical diagnostic reagents for scientific use
• Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Health food supplements; Nutraceuticals for use as a dietary supplement; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical reagents for medical use; Chemical reagents for medical or veterinary use; Diagnostic chemical reagents for medical purposes; Diagnostic chemical reagents for medical use; Reagents for medical use; Clinical medical reagents; Dietary and nutritional supplements; Dietary food supplements; Vitamin and mineral supplements; Herbal supplements; Human vaccine preparations; Vaccine preparations
• Class 040 — Treatment of materials: Biomanufacturing for others of pharmaceuticals using biological organisms in the manufacturing process; Custom manufacture of cancer vaccines; Custom manufacturing of pharmaceuticals
• Class 042 — Scientific and technological services: Research and development in the field of pharmaceuticals; Development of products for others in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Development of pharmaceuticals for cell and gene therapies; Research and development of new products; Technical consulting in the field of pharmaceutical studies; Research and development services of new pharmaceutical products; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Biomedical research services
• Class 044 — Medical, beauty and agricultural services: Medical services; Medical clinics; Health care services, namely, wellness programs; Providing a website featuring information about health, wellness and nutrition; Providing information in the fields of health and wellness; Managed health care services; Consulting services in the field of healthcare

Owner

• Zylidac Bio LLC, Pennington, NJ, US

Prosecution history

• 17 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 17 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
• 17 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 17 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
• 17 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
• 17 Mar 2026 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
• 10 Mar 2026 — WITHDRAWN FROM PUB - OG REVIEW QUERY
• 18 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 18 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
• 18 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 18 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
• 18 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
• 17 Feb 2026 — ASSIGNED TO EXAMINER
• 13 Feb 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
• 13 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED